Skip to main content
HUONS CO., LTD. logo

HUONS CO., LTD. — Investor Relations & Filings

Ticker · 243070 ISIN · KR7243070000 KO Manufacturing
Open in API
Filings indexed 391 across all filing types
Latest filing 2026-06-04 Declaration of Voting R…
Country KR South Korea
Listing KO 243070

About HUONS CO., LTD.

https://www.huons.com/en

HUONS CO., LTD. is an integrated pharmaceutical and healthcare company founded in 1965. The company develops and manufactures a wide range of finished pharmaceutical products, medical solutions, and medical devices under cGMP standards. It was a pioneer in its domestic market, developing the first plastic ampule injections and local anesthetics. The company's research and development efforts focus on key therapeutic areas including ophthalmology, osteoarthritis, dermatology, wellness, and Central Nervous System (CNS) disorders. Its diversified portfolio also extends to bio products, eye drops, cosmetics, and health functional foods, aiming to provide comprehensive healthcare solutions.

Recent filings

Filing Released Lang Actions
[기재정정]주주명부폐쇄기간또는기준일설정
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a regulatory disclosure in Korean concerning the setting (and correction) of the shareholders’ register closure period and record date (“주주명부폐쇄기간 또는 기준일 설정”) for the purpose of determining voting rights at an upcoming general meeting. It specifically announces the record date (2026-07-30) and related board resolutions. This is not financial statements or management discussion; rather, it is an announcement of voting‐rights entitlements. Under our taxonomy, this falls under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-06-04 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 95% confidence The text is a Korean “주요사항보고서(회사합병결정)” — a material fact report announcing and detailing a corporate merger (merger decision, ratio, schedule, appraisal opinions, etc.). This is a merger announcement and falls squarely under M&A Activity filings (Code TAR).
2026-06-04 Korean
[기재정정]주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a notice of convocation (“주주총회소집 결의”) for an extraordinary shareholders’ meeting, providing meeting date, venue, record date changes, and detailed agenda items for shareholders to review and vote upon. This fits the category for materials sent to shareholders to provide information and request votes (Proxy Solicitation & Information Statement).
2026-06-04 Korean
[기재정정]주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a Korean regulatory disclosure of a resolution to convene an extraordinary shareholders meeting (임시주주총회), detailing the date, venue, record date, agenda items (merger approval, articles amendment), and related amendments. It constitutes the proxy solicitation/information statement category, i.e., the formal notice and information sent to shareholders to request their votes at the meeting. Thus, the best match is Proxy Solicitation & Information Statement (PSI).
2026-05-28 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 85% confidence The document is a mandatory disclosure (주요사항보고서) filed with the Korean regulator/KRX announcing and detailing the company’s decision to effect a merger (흡수합병) with another entity. It includes merger ratio, valuation, timetable, and other contract terms. This clearly falls under announcements and documents related to merger proposals and takeover bids. Therefore, it should be classified as M&A Activity, code TAR.
2026-05-28 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 95% confidence The document is a Korean "주요사항보고서(회사합병 결정)" filed with the Financial Services Commission and Korea Exchange, detailing the decision to absorb‐merge a subsidiary into the listed parent, including merger ratio, valuation, timetable, and shareholder rights provisions. This is a corporate action announcement concerning a merger proposal, fitting the M&A Activity category rather than a standard financial report or proxy. Therefore it is classified as M&A Activity (TAR).
2026-05-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.